Anne O'Donnell Luria, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rare Diseases | 8 | 2023 | 553 | 1.570 |
Why?
|
| Genetic Variation | 14 | 2023 | 6544 | 0.920 |
Why?
|
| Genomics | 11 | 2023 | 5720 | 0.820 |
Why?
|
| Inheritance Patterns | 1 | 2023 | 340 | 0.780 |
Why?
|
| Phenotype | 26 | 2023 | 16365 | 0.600 |
Why?
|
| Hyperammonemia | 1 | 2017 | 76 | 0.550 |
Why?
|
| Genetic Association Studies | 9 | 2022 | 2703 | 0.540 |
Why?
|
| Heterozygote | 4 | 2021 | 2804 | 0.500 |
Why?
|
| Genetic Testing | 5 | 2023 | 3444 | 0.490 |
Why?
|
| Glutamine | 1 | 2017 | 578 | 0.470 |
Why?
|
| Genome, Human | 10 | 2023 | 4420 | 0.450 |
Why?
|
| Coma | 1 | 2017 | 475 | 0.450 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 326 | 0.440 |
Why?
|
| Software | 4 | 2022 | 4443 | 0.410 |
Why?
|
| Haploinsufficiency | 4 | 2023 | 328 | 0.400 |
Why?
|
| Genome | 7 | 2023 | 1808 | 0.400 |
Why?
|
| Penetrance | 4 | 2023 | 381 | 0.390 |
Why?
|
| Arthrogryposis | 2 | 2022 | 72 | 0.370 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2023 | 17446 | 0.370 |
Why?
|
| Muscular Dystrophies | 2 | 2023 | 393 | 0.350 |
Why?
|
| DNA Methylation | 6 | 2014 | 4286 | 0.330 |
Why?
|
| Cytosine | 1 | 2009 | 216 | 0.320 |
Why?
|
| Microcephaly | 2 | 2023 | 432 | 0.300 |
Why?
|
| Epilepsy | 2 | 2021 | 3310 | 0.290 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3760 | 0.280 |
Why?
|
| Databases, Genetic | 7 | 2023 | 1783 | 0.280 |
Why?
|
| Sequence Analysis, DNA | 7 | 2023 | 4803 | 0.280 |
Why?
|
| Gene Frequency | 6 | 2023 | 3588 | 0.260 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2021 | 1676 | 0.260 |
Why?
|
| Mutation | 17 | 2023 | 29786 | 0.250 |
Why?
|
| Isotopes | 1 | 2004 | 124 | 0.250 |
Why?
|
| alpha-Glucosidases | 1 | 2004 | 44 | 0.250 |
Why?
|
| Consanguinity | 2 | 2017 | 454 | 0.250 |
Why?
|
| Disease | 2 | 2020 | 680 | 0.240 |
Why?
|
| Turner Syndrome | 1 | 2015 | 130 | 0.230 |
Why?
|
| Developmental Disabilities | 4 | 2023 | 1456 | 0.230 |
Why?
|
| Genetic Counseling | 2 | 2021 | 600 | 0.230 |
Why?
|
| Mammals | 1 | 2009 | 1143 | 0.230 |
Why?
|
| Solvents | 1 | 2004 | 302 | 0.230 |
Why?
|
| Pedigree | 6 | 2021 | 4644 | 0.230 |
Why?
|
| Exons | 3 | 2023 | 2437 | 0.210 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 9648 | 0.200 |
Why?
|
| Nanopores | 1 | 2022 | 50 | 0.200 |
Why?
|
| Humans | 75 | 2023 | 744343 | 0.200 |
Why?
|
| Intranuclear Space | 1 | 2021 | 15 | 0.200 |
Why?
|
| Homozygote | 4 | 2021 | 1785 | 0.200 |
Why?
|
| Primates | 1 | 2023 | 545 | 0.190 |
Why?
|
| Repressor Proteins | 3 | 2020 | 3023 | 0.190 |
Why?
|
| Calibration | 1 | 2022 | 816 | 0.180 |
Why?
|
| Chloride Channels | 1 | 2021 | 227 | 0.180 |
Why?
|
| CpG Islands | 4 | 2020 | 1172 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2023 | 3597 | 0.180 |
Why?
|
| Uniparental Disomy | 1 | 2019 | 43 | 0.180 |
Why?
|
| Selection, Genetic | 3 | 2023 | 914 | 0.180 |
Why?
|
| Ophthalmoplegia | 1 | 2021 | 166 | 0.180 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2022 | 256 | 0.170 |
Why?
|
| Histone Acetyltransferases | 1 | 2021 | 336 | 0.170 |
Why?
|
| Brain | 9 | 2022 | 26385 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2023 | 445 | 0.170 |
Why?
|
| Adenosine Deaminase | 1 | 2021 | 241 | 0.170 |
Why?
|
| 5' Untranslated Regions | 1 | 2020 | 249 | 0.170 |
Why?
|
| Chromosome Mapping | 4 | 2023 | 4740 | 0.170 |
Why?
|
| Genes, Essential | 1 | 2020 | 183 | 0.170 |
Why?
|
| Anemia, Megaloblastic | 1 | 2018 | 25 | 0.160 |
Why?
|
| Hydroxocobalamin | 1 | 2018 | 31 | 0.160 |
Why?
|
| Multifactorial Inheritance | 2 | 2023 | 1194 | 0.160 |
Why?
|
| Malformations of Cortical Development | 1 | 2021 | 200 | 0.160 |
Why?
|
| Infertility, Female | 1 | 2015 | 787 | 0.160 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 305 | 0.160 |
Why?
|
| Uncertainty | 1 | 2023 | 734 | 0.160 |
Why?
|
| Eczema | 1 | 2020 | 231 | 0.160 |
Why?
|
| Membrane Glycoproteins | 2 | 2020 | 3768 | 0.150 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2018 | 137 | 0.150 |
Why?
|
| Physicians | 1 | 2016 | 4567 | 0.150 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 528 | 0.150 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 544 | 0.150 |
Why?
|
| Sodium Benzoate | 1 | 2017 | 15 | 0.150 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2017 | 51 | 0.150 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2021 | 357 | 0.150 |
Why?
|
| Genetics, Medical | 1 | 2020 | 338 | 0.150 |
Why?
|
| Xenopus Proteins | 1 | 2020 | 433 | 0.150 |
Why?
|
| Tubulin | 1 | 2021 | 695 | 0.150 |
Why?
|
| Phenylacetates | 1 | 2017 | 114 | 0.150 |
Why?
|
| Marfan Syndrome | 1 | 2019 | 240 | 0.150 |
Why?
|
| Cerebral Palsy | 1 | 2022 | 459 | 0.150 |
Why?
|
| Neuropeptides | 1 | 2023 | 942 | 0.150 |
Why?
|
| Nephrotic Syndrome | 1 | 2021 | 389 | 0.140 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2018 | 132 | 0.140 |
Why?
|
| Embryo, Nonmammalian | 1 | 2020 | 895 | 0.140 |
Why?
|
| DNA Mutational Analysis | 4 | 2020 | 4186 | 0.140 |
Why?
|
| Multigene Family | 1 | 2019 | 1102 | 0.140 |
Why?
|
| Ion Channels | 1 | 2021 | 1056 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2021 | 5021 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 728 | 0.130 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 12261 | 0.130 |
Why?
|
| Glutamates | 1 | 2017 | 398 | 0.130 |
Why?
|
| Body Patterning | 1 | 2020 | 626 | 0.130 |
Why?
|
| Gene Deletion | 3 | 2019 | 2751 | 0.130 |
Why?
|
| Growth Disorders | 1 | 2020 | 645 | 0.130 |
Why?
|
| Models, Genetic | 2 | 2023 | 3494 | 0.130 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 733 | 0.130 |
Why?
|
| Facies | 3 | 2021 | 197 | 0.130 |
Why?
|
| Genetics, Population | 1 | 2020 | 934 | 0.130 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 2126 | 0.130 |
Why?
|
| Prion Diseases | 1 | 2016 | 88 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2020 | 838 | 0.120 |
Why?
|
| Genotype | 7 | 2023 | 12951 | 0.120 |
Why?
|
| Fibrosis | 1 | 2021 | 2029 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 587 | 0.120 |
Why?
|
| Autistic Disorder | 1 | 2023 | 1185 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2021 | 849 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 1179 | 0.110 |
Why?
|
| Histones | 2 | 2022 | 2599 | 0.110 |
Why?
|
| Genes | 1 | 2017 | 1893 | 0.110 |
Why?
|
| Child, Preschool | 9 | 2022 | 41006 | 0.110 |
Why?
|
| Health | 1 | 2016 | 394 | 0.110 |
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 824 | 0.110 |
Why?
|
| Craniosynostoses | 1 | 2017 | 401 | 0.110 |
Why?
|
| Child | 13 | 2023 | 77709 | 0.110 |
Why?
|
| Mutation, Missense | 4 | 2023 | 2564 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 670 | 0.100 |
Why?
|
| Alleles | 5 | 2021 | 6933 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2023 | 4462 | 0.100 |
Why?
|
| Female | 27 | 2023 | 380194 | 0.100 |
Why?
|
| Male | 28 | 2022 | 350118 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2021 | 4584 | 0.090 |
Why?
|
| Databases, Nucleic Acid | 1 | 2011 | 211 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2916 | 0.090 |
Why?
|
| Zebrafish | 1 | 2022 | 2994 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2014 | 625 | 0.090 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 1791 | 0.090 |
Why?
|
| Computational Biology | 2 | 2019 | 3521 | 0.090 |
Why?
|
| Internet | 1 | 2022 | 3064 | 0.090 |
Why?
|
| Base Sequence | 3 | 2023 | 12797 | 0.090 |
Why?
|
| Psychiatry | 1 | 2022 | 1695 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1788 | 0.080 |
Why?
|
| Infant | 6 | 2021 | 35136 | 0.080 |
Why?
|
| Adolescent | 10 | 2022 | 85781 | 0.080 |
Why?
|
| Gastric Bypass | 1 | 2017 | 812 | 0.080 |
Why?
|
| HEK293 Cells | 3 | 2023 | 4204 | 0.080 |
Why?
|
| Access to Information | 2 | 2023 | 320 | 0.080 |
Why?
|
| Open Reading Frames | 2 | 2022 | 810 | 0.080 |
Why?
|
| Mood Disorders | 1 | 2014 | 1106 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 15519 | 0.070 |
Why?
|
| Methyltransferases | 1 | 2009 | 367 | 0.070 |
Why?
|
| Animals | 15 | 2023 | 168757 | 0.070 |
Why?
|
| Patient Selection | 1 | 2018 | 4215 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7722 | 0.070 |
Why?
|
| Pakistan | 2 | 2017 | 295 | 0.070 |
Why?
|
| Nucleosomes | 1 | 2009 | 494 | 0.070 |
Why?
|
| Methylglucosides | 1 | 2004 | 36 | 0.060 |
Why?
|
| Deuterium Oxide | 1 | 2004 | 34 | 0.060 |
Why?
|
| Syndrome | 2 | 2022 | 3251 | 0.060 |
Why?
|
| Evolution, Molecular | 2 | 2011 | 1940 | 0.060 |
Why?
|
| Buffers | 1 | 2004 | 147 | 0.060 |
Why?
|
| Proteins | 1 | 2020 | 6103 | 0.060 |
Why?
|
| Chromatin | 2 | 2022 | 2934 | 0.060 |
Why?
|
| Enzyme Stability | 1 | 2004 | 210 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 13815 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 12072 | 0.060 |
Why?
|
| Suicide | 1 | 2014 | 1477 | 0.060 |
Why?
|
| National Human Genome Research Institute (U.S.) | 1 | 2023 | 23 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2004 | 682 | 0.060 |
Why?
|
| Dystroglycans | 1 | 2023 | 60 | 0.060 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2023 | 61 | 0.060 |
Why?
|
| Karyotyping | 1 | 2015 | 1243 | 0.050 |
Why?
|
| Informatics | 1 | 2023 | 72 | 0.050 |
Why?
|
| Cell Line | 3 | 2021 | 15997 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2022 | 40561 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18029 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2022 | 6600 | 0.050 |
Why?
|
| Transcription Factors | 3 | 2023 | 12208 | 0.050 |
Why?
|
| Blepharophimosis | 1 | 2021 | 22 | 0.050 |
Why?
|
| Congenital Hypothyroidism | 1 | 2021 | 39 | 0.050 |
Why?
|
| Connexins | 1 | 2023 | 357 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13284 | 0.050 |
Why?
|
| Dystrophin | 1 | 2023 | 285 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2022 | 13033 | 0.050 |
Why?
|
| Mice | 8 | 2023 | 81183 | 0.050 |
Why?
|
| Adult | 9 | 2022 | 214055 | 0.050 |
Why?
|
| S Phase | 1 | 2002 | 423 | 0.050 |
Why?
|
| Glucosyltransferases | 1 | 2021 | 98 | 0.050 |
Why?
|
| Scrotum | 1 | 2021 | 115 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2021 | 173 | 0.050 |
Why?
|
| Psychomotor Disorders | 1 | 2021 | 152 | 0.050 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2020 | 38 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1801 | 0.050 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2015 | 482 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 2915 | 0.040 |
Why?
|
| Radiation Tolerance | 1 | 2002 | 486 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2557 | 0.040 |
Why?
|
| Myoblasts | 1 | 2021 | 238 | 0.040 |
Why?
|
| Patella | 1 | 2021 | 320 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 281 | 0.040 |
Why?
|
| Genetic Loci | 2 | 2021 | 2575 | 0.040 |
Why?
|
| User-Computer Interface | 2 | 2019 | 1431 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2023 | 853 | 0.040 |
Why?
|
| Protons | 1 | 2004 | 1127 | 0.040 |
Why?
|
| Glycine | 1 | 2022 | 671 | 0.040 |
Why?
|
| Autopsy | 1 | 2023 | 1020 | 0.040 |
Why?
|
| Siblings | 1 | 2023 | 854 | 0.040 |
Why?
|
| Psychopathology | 1 | 2022 | 409 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2020 | 513 | 0.040 |
Why?
|
| Craniofacial Abnormalities | 1 | 2021 | 315 | 0.040 |
Why?
|
| Arginine | 1 | 2022 | 944 | 0.040 |
Why?
|
| Virulence | 1 | 2022 | 1333 | 0.040 |
Why?
|
| Immune System Diseases | 1 | 2021 | 262 | 0.040 |
Why?
|
| Aging | 2 | 2014 | 8664 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 794 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
| Australia | 1 | 2021 | 1170 | 0.040 |
Why?
|
| Filipin | 1 | 2017 | 13 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2021 | 514 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 56430 | 0.040 |
Why?
|
| Temperature | 1 | 2004 | 2206 | 0.040 |
Why?
|
| Middle Aged | 8 | 2021 | 213383 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2018 | 136 | 0.040 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 328 | 0.040 |
Why?
|
| Neuregulins | 1 | 2017 | 35 | 0.040 |
Why?
|
| Collagen Type VI | 1 | 2017 | 26 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2023 | 1117 | 0.040 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2018 | 116 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2018 | 240 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 11725 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 107 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 552 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2023 | 4931 | 0.040 |
Why?
|
| Podocytes | 1 | 2021 | 396 | 0.040 |
Why?
|
| Kinetics | 1 | 2004 | 6473 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.040 |
Why?
|
| Binding Sites | 2 | 2021 | 6114 | 0.040 |
Why?
|
| Ribosomal Proteins | 1 | 2018 | 360 | 0.030 |
Why?
|
| Reference Standards | 1 | 2020 | 1025 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 440 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2021 | 739 | 0.030 |
Why?
|
| Liver Failure, Acute | 1 | 2017 | 165 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2020 | 957 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2019 | 530 | 0.030 |
Why?
|
| Germ Cells | 1 | 2020 | 631 | 0.030 |
Why?
|
| Muscles | 1 | 2021 | 1614 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 209 | 0.030 |
Why?
|
| Face | 1 | 2022 | 994 | 0.030 |
Why?
|
| Apolipoprotein C-III | 1 | 2017 | 202 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2002 | 1149 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 1236 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 242 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2017 | 292 | 0.030 |
Why?
|
| Kidney | 2 | 2021 | 7186 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9438 | 0.030 |
Why?
|
| Ribosomes | 1 | 2018 | 500 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 1695 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 780 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 6622 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2021 | 3128 | 0.030 |
Why?
|
| Educational Status | 1 | 2022 | 2540 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2019 | 1252 | 0.030 |
Why?
|
| Haplotypes | 1 | 2021 | 2779 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1850 | 0.030 |
Why?
|
| Prions | 1 | 2016 | 180 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14557 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2017 | 690 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2021 | 1416 | 0.030 |
Why?
|
| Joint Instability | 1 | 2021 | 792 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 63114 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3798 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2752 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 386 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 2109 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 2959 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1184 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 845 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 809 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2017 | 556 | 0.030 |
Why?
|
| Glucose | 1 | 2004 | 4397 | 0.030 |
Why?
|
| Prevalence | 2 | 2019 | 15226 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 1941 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 19905 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2021 | 1708 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2021 | 1703 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2018 | 1301 | 0.030 |
Why?
|
| Fathers | 1 | 2014 | 358 | 0.030 |
Why?
|
| Pregnancy | 2 | 2023 | 29144 | 0.020 |
Why?
|
| Fertility | 1 | 2016 | 781 | 0.020 |
Why?
|
| Fasting | 1 | 2017 | 1593 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2021 | 5456 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2018 | 1099 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 159 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 6171 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2021 | 25625 | 0.020 |
Why?
|
| Triglycerides | 1 | 2017 | 2454 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2017 | 2017 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2309 | 0.020 |
Why?
|
| Algorithms | 2 | 2021 | 13881 | 0.020 |
Why?
|
| Seizures | 1 | 2021 | 2859 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 23338 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2017 | 2440 | 0.020 |
Why?
|
| DNA | 1 | 2022 | 7301 | 0.020 |
Why?
|
| Mental Health | 1 | 2022 | 3019 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2007 | 229 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1799 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 1637 | 0.020 |
Why?
|
| Epigenesis, Genetic | 2 | 2011 | 3647 | 0.020 |
Why?
|
| Epigenomics | 1 | 2011 | 903 | 0.020 |
Why?
|
| Mothers | 1 | 2016 | 2165 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 1912 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5319 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16689 | 0.020 |
Why?
|
| Cognition | 1 | 2022 | 6770 | 0.020 |
Why?
|
| Motor Activity | 1 | 2014 | 2714 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7880 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2007 | 1202 | 0.010 |
Why?
|
| United States | 2 | 2023 | 69872 | 0.010 |
Why?
|
| Risk Factors | 2 | 2023 | 72290 | 0.010 |
Why?
|
| Species Specificity | 1 | 2007 | 2478 | 0.010 |
Why?
|
| G2 Phase | 1 | 2002 | 139 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2017 | 6077 | 0.010 |
Why?
|
| Liver | 1 | 2017 | 7474 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7799 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 163280 | 0.010 |
Why?
|
| Breast | 1 | 2010 | 1969 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15540 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3846 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1294 | 0.010 |
Why?
|
| Serine | 1 | 2002 | 826 | 0.010 |
Why?
|
| Genes, BRCA1 | 1 | 2002 | 781 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21746 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23403 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29063 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18370 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 11727 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6314 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15165 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 5892 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 35421 | 0.010 |
Why?
|
| DNA Damage | 1 | 2002 | 2432 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 2849 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 57776 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 8436 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 3462 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 20822 | 0.000 |
Why?
|